Literature DB >> 6780369

Influence of cimetidine on the pharmacokinetics of desmethyldiazepam and oxazepam.

U Klotz, I Reimann.   

Abstract

The pharmacokinetics of single oral doses of desmethyldiazepam 20 mg or oxazepam 50 mg were studied in 5 healthy volunteers under controlled conditions, before and following a 24 h pretreatment with cimetidine 200 mg x 5. Cimetidine significantly impaired (p = 0.03) the elimination of desmethyldiazepam, as shown prolongation of its elimination half-life from 51.7 +/- 21.9 h to 72.6 +/- 39.4 h (mean +/- SD), and a decrease in total plasma clearance from 12.0 +/- 2.7 ml/min to 8.6 +/- 3.3 ml/min. The disposition of oxazepam was not affected. From these results, and recently published data on diazepam and chlordiazepoxide, it is concluded that cimetidine impairs the hepatic elimination of those benzodiazepines which are metabolized by phase I reactions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6780369     DOI: 10.1007/BF00874666

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  Effects of aging and liver disease on disposition of lorazepam.

Authors:  J W Kraus; P V Desmond; J P Marshall; R F Johnson; S Schenker; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1978-10       Impact factor: 6.875

2.  Cimetidine/diazepam interaction.

Authors:  U Klotz; V J Anttila; T Reimann
Journal:  Lancet       Date:  1979-09-29       Impact factor: 79.321

3.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

4.  Altered elimination of desmethyldiazepam in the elderly.

Authors:  U Klotz; P Müller-Seydlitz
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

5.  Cimetidine inhibits microsomal drug metabolism in the rat.

Authors:  J Puurunen; O Pelkonen
Journal:  Eur J Pharmacol       Date:  1979-05-01       Impact factor: 4.432

6.  Delayed clearance of diazepam due to cimetidine.

Authors:  U Klotz; I Reimann
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

7.  The effects of age and liver disease on the disposition and elimination of diazepam in adult man.

Authors:  U Klotz; G R Avant; A Hoyumpa; S Schenker; G R Wilkinson
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

8.  Cimetidine: interaction with oral anticoagulants in man.

Authors:  M J Serlin; R G Sibeon; S Mossman; A M Breckenridge; J R Williams; J L Atwood; J M Willoughby
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

9.  Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium).

Authors:  R K Roberts; G R Wilkinson; R A Branch; S Schenker
Journal:  Gastroenterology       Date:  1978-09       Impact factor: 22.682

10.  Cimetidine spares the glucuronidation of lorazepam and oxazepam.

Authors:  R V Patwardhan; G W Yarborough; P V Desmond; R F Johnson; S Schenker; K V Speeg
Journal:  Gastroenterology       Date:  1980-11       Impact factor: 22.682

View more
  31 in total

1.  Effect of orally administered misoprostol and cimetidine on the steady state pharmacokinetics of diazepam and nordiazepam in human volunteers.

Authors:  D R Lima; R M Santos; E Werneck; G N Andrade
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jul-Sep       Impact factor: 2.441

2.  Potentially lethal interaction of cimetidine and morphine.

Authors:  P Mojaverian; B N Swanson; P H Vlasses; R K Ferguson
Journal:  Can Med Assoc J       Date:  1981-12-01       Impact factor: 8.262

3.  Drug interactions through binding to cytochrome p 450: the experience with h2-receptor blocking agents.

Authors:  U Klotz; I W Reimann
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

Review 4.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

5.  Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.

Authors:  U Klotz; P Arvela; B Rosenkranz
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Cimetidine versus famotidine: the effect on the pharmacokinetics of theophylline in rats.

Authors:  P Mojaverian; M L Rocci; C L Saccar; P H Vlasses; R K Ferguson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Apr-Jun       Impact factor: 2.441

7.  Obesity effects on nitrazepam disposition.

Authors:  D R Abernethy; D J Greenblatt; A Locniskar; H R Ochs; J S Harmatz; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

8.  Influence of cimetidine on steady state concentration and metabolite formation from antipyrine infused with a rectal osmotic mini pump.

Authors:  M W Teunissen; C H Kleinbloesem; L G de Leede; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  The pharmacokinetics of midazolam following orthotopic liver transplantation.

Authors:  M P Shelly; J S Dixon; G R Park
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

10.  Disposition of clotiazepam: influence of age, sex, oral contraceptives, cimetidine, isoniazid and ethanol.

Authors:  H R Ochs; D J Greenblatt; B Verburg-Ochs; J S Harmatz; H Grehl
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.